Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 9 min read

This article was created with AI assistance.

ICU Sedation & Analgesia: The Big Picture

Part of the ICU Pharmacology Hub — browse every related guide in one place.

Managing a ventilated patient's comfort is one of the most consequential things an ICU nurse does. Get it right and the patient is calm, synchronous, and liberated from the vent quickly. Get it wrong — too deep, too long, wrong drug — and you buy extra ventilator days, delirium, weakness, and PTSD. This guide ties together the individual drugs into the framework modern critical care actually uses.

The core principle: Modern ICU sedation is analgesia-first, light, and targeted. Treat pain before piling on sedatives, aim for the lightest safe sedation (usually RASS 0 to -2), screen for delirium every shift, interrupt sedation daily, and get patients awake, moving, and off the vent as fast as safely possible. The drugs are tools; the framework is what protects the patient.

Analgosedation: why pain comes first

For years, ICUs sedated ventilated patients deeply by default. The evidence turned that on its head. Much of what looks like agitation is actually untreated pain — the endotracheal tube, procedures, immobility, surgical wounds. The analgosedation approach treats pain first (usually with a fentanyl infusion), then adds only as much sedative as still needed. Many patients need far less sedation once pain is controlled, and some tolerate the vent on analgesia alone.

Measuring what you're doing: the scales

You can't titrate to a target you don't measure. Three validated tools structure ICU comfort management:

DomainToolWhat it measures
Sedation depthRASSRichmond Agitation-Sedation Scale, +4 (combative) to -5 (unarousable)
Pain (nonverbal)CPOT / BPSBehavioral pain in patients who can't self-report
DeliriumCAM-ICU / ICDSCPresence of acute confusion / inattention

A typical light-sedation target is RASS 0 to -2 — calm, drowsy, rouses to voice. Deeper targets (RASS -3 to -5) are reserved for specific situations like severe ARDS, paralysis, refractory intracranial hypertension, or status epilepticus.

Choosing the sedative

There's no single "best" sedative — the right one depends on the goal.

Propofol — fast on/off, controllable, good when you need deeper sedation or frequent neuro checks. Watch hypotension, triglycerides, and PRIS.

Dexmedetomidine (Precedex) — light, cooperative sedation with minimal respiratory depression; favored for weaning and delirium-prone patients. Watch bradycardia and hypotension.

Benzodiazepines (midazolam, lorazepam) — still used for status epilepticus, alcohol withdrawal, and deep sedation needs, but de-emphasized for routine sedation because of their strong association with delirium.

Rule of thumb: pain → opioid first. Light, cooperative target → dexmedetomidine. Need deeper/controllable sedation or rapid wake-ups → propofol. Reserve benzodiazepines for specific indications, not default sedation.

Deep sedation and paralysis

Some situations require deep sedation, and a few require neuromuscular blockade on top of it — severe ARDS, dangerous vent dyssynchrony, shivering during targeted temperature management. The absolute rule when paralyzing: sedation and analgesia must be adequate and continuous, because a paralyzed patient cannot show you pain or awareness. Under-sedated paralysis is a catastrophic, preventable harm.

The A-to-F bundle: the framework that ties it together

Most high-performing ICUs organize comfort and liberation around the ABCDEF (A2F) bundle:

LetterElement
AAssess, prevent, and manage pain
BBoth spontaneous awakening trials (SAT) & spontaneous breathing trials (SBT)
CChoice of analgesia and sedation
DDelirium: assess, prevent, manage
EEarly mobility and exercise
FFamily engagement and empowerment

The nurse drives most of this bundle at the bedside: running the daily awakening trial, screening delirium with CAM-ICU, coordinating the breathing trial with RT, and getting patients up and moving. Consistent bundle use is linked to less delirium, fewer ventilator days, and better survival.

The daily awakening trial

Once a day (when safe), sedation is paused to let the patient wake — a spontaneous awakening trial — usually paired with a spontaneous breathing trial. This prevents drug accumulation, reveals the patient's true neuro status, and shortens time on the vent. Contraindications (active seizures, escalating pressors, paralysis, severe agitation risk) exist, so it's protocolized — but when appropriate, it's one of the most powerful interventions in critical care, and it's nurse-led.

Why this matters for the CRNA path

Sedation and analgesia are the daily language of anesthesia. The judgment you build in the ICU — matching drug to goal, titrating to a measured target, respecting hemodynamics, and thinking about emergence — is the same judgment nurse anesthetists use in the OR. ICU nurses who understand not just the individual drugs but the framework around them arrive on the CRNA path already thinking like anesthesia providers.

Bottom line

Sedation isn't about keeping patients still — it's about keeping them comfortable, safe, and moving toward liberation. Treat pain first, sedate light and to a measured target, screen for delirium, interrupt sedation daily, and run the A-to-F bundle. Know propofol, fentanyl, and dexmedetomidine as tools inside that framework, and you'll manage ventilated patients the way the best units do.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.

Get the ICU Notebook

Free investing strategies built for nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.